Literature DB >> 24219820

Predicting mortality in patients with in-hospital nonvariceal upper GI bleeding: a prospective, multicenter database study.

Riccardo Marmo1, Maurizio Koch2, Livio Cipolletta3, Maria Antonia Bianco3, Enzo Grossi4, Gianluca Rotondano3.   

Abstract

BACKGROUND: Nonvariceal upper GI bleeding (NVUGIB) that occurs in patients already hospitalized for another condition is associated with increased mortality, but outcome predictors have not been consistently identified.
OBJECTIVE: To assess clinical outcomes of NVUGIB and identify predictors of mortality from NVUGIB in patients with in-hospital bleeding compared with outpatients.
DESIGN: Secondary analysis of prospectively collected data from 2 nationwide multicenter databases. Descriptive, inferential, and multivariate logistic regression models were carried out in 338 inpatients (68.6 ± 16.4 years of age, 68% male patients) and 1979 outpatients (67.8 ± 17 years of age, 66% male patients). A predictive model was constructed using the risk factors identified at multivariate analysis, weighted according to the contribution of each factor. SETTINGS: A total of 23 Italian community and tertiary care centers. PATIENTS: Consecutive patients admitted for acute NVUGIB.
INTERVENTIONS: Early endoscopy, medical and endoscopic treatment as appropriate. MAIN OUTCOME MEASUREMENTS: Recurrent bleeding, surgery, and 30-day mortality.
RESULTS: The mortality rate in patients with in-hospital bleeding was significantly higher than that in outpatients (8.9% vs 3.8%; odds ratio [OR] 2.44; 95% confidence interval [CI], 1.57-3.79; P < .0001). Hemodynamic instability on presentation (OR 7.31; 95% CI, 2.71-19.65) and the presence of severe comorbidity (OR 6.72; 95% CI, 1.87-24.0) were the strongest predictors of death for in-hospital bleeders. Other independent predictors of mortality were a history of peptic ulcer disease and failed endoscopic treatment. Rebleeding was a strong predictor of death only for outpatients (OR 5.22; 95% CI, 2.45-11.10). Risk factors had a different prognostic impact on the 2 populations, resulting in a significantly different prognostic accuracy of the model (area under the receiver-operating characteristic curve = 0.83; 95% CI, 0.77-0-93 vs 0.74; 95% CI, 0.68-0.80; P < .02). LIMITATIONS: Study design not experimental, no data on ward specialty, potential referral bias.
CONCLUSIONS: In-hospital bleeders have a significantly higher risk of death because they are sicker and more often hemodynamically unstable than outpatients. Predictors of death have a different impact in the 2 populations.
Copyright © 2014 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24219820     DOI: 10.1016/j.gie.2013.10.009

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  20 in total

1.  Management for non-variceal upper gastrointestinal bleeding in elderly patients: the experience of a tertiary university hospital.

Authors:  Koichiro Kawaguchi; Hiroki Kurumi; Yohei Takeda; Kazuo Yashima; Hajime Isomoto
Journal:  Ann Transl Med       Date:  2017-04

2.  Successful Endoscopic Hemostasis Is a Protective Factor for Rebleeding and Mortality in Patients with Nonvariceal Upper Gastrointestinal Bleeding.

Authors:  Yong Jae Han; Jae Myung Cha; Jae Hyun Park; Jung Won Jeon; Hyun Phil Shin; Kwang Ro Joo; Joung Il Lee
Journal:  Dig Dis Sci       Date:  2016-02-29       Impact factor: 3.199

3.  Risk Factors for Adverse Outcomes in Patients Hospitalized With Lower Gastrointestinal Bleeding.

Authors:  Neil Sengupta; Elliot B Tapper; Vilas R Patwardhan; Gyanprakash A Ketwaroo; Adarsh M Thaker; Daniel A Leffler; Joseph D Feuerstein
Journal:  Mayo Clin Proc       Date:  2015-07-02       Impact factor: 7.616

Review 4.  Endoscopy for nonvariceal upper gastrointestinal bleeding.

Authors:  Ki Bae Kim; Soon Man Yoon; Sei Jin Youn
Journal:  Clin Endosc       Date:  2014-07-28

5.  Cost-effectiveness of check of medication appropriateness: methodological approach.

Authors:  Erinn D'hulster; Charlotte Quintens; Jeroen Luyten; Raf Bisschops; Rik Willems; Willy E Peetermans; Jan Y Verbakel
Journal:  Int J Clin Pharm       Date:  2022-01-11

6.  Clinical characteristics of Helicobacter pylori-negative drug-negative peptic ulcer bleeding.

Authors:  Woo Chul Chung; Eun Jung Jeon; Dae Bum Kim; Hea Jung Sung; Yeon-Ji Kim; Eun Sun Lim; Min-Ah Kim; Jung Hwan Oh
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

7.  Randomized Controlled Trial of Over-the-Scope Clip as Initial Treatment of Severe Nonvariceal Upper Gastrointestinal Bleeding.

Authors:  Dennis M Jensen; Thomas Kovacs; Kevin A Ghassemi; Marc Kaneshiro; Jeffrey Gornbein
Journal:  Clin Gastroenterol Hepatol       Date:  2020-08-20       Impact factor: 11.382

8.  Prophylactic tracheal intubation for upper GI bleeding: A meta-analysis.

Authors:  Ashraf A Almashhrawi; Rubayat Rahman; Samuel T Jersak; Akwi W Asombang; Alisha M Hinds; Hazem T Hammad; Douglas L Nguyen; Matthew L Bechtold
Journal:  World J Metaanal       Date:  2015-02-26

9.  Validity of peptic ulcer disease and upper gastrointestinal bleeding diagnoses in administrative databases: a systematic review protocol.

Authors:  Alessandro Montedori; Iosief Abraha; Carlos Chiatti; Francesco Cozzolino; Massimiliano Orso; Maria Laura Luchetta; Joseph M Rimland; Giuseppe Ambrosio
Journal:  BMJ Open       Date:  2016-09-15       Impact factor: 2.692

10.  Prognosis of variceal and non-variceal upper gastrointestinal bleeding in already hospitalised patients: Results from a French prospective cohort.

Authors:  Weam El Hajj; Vincent Quentin; Gaelle Boudoux D'Hautefeuille; Helene Vandamme; Chantal Berger; Mohammed Redha Moussaoui; Aliou Berete; Dominique Louvel; Jean Guy Bertolino; Emmanuel Cuillerier; Quentin Thiebault; Yves Arondel; Sylvie Grimbert; Brigitte Le Guillou; Isabelle Borel; Pierre Lahmek; Stéphane Nahon
Journal:  United European Gastroenterol J       Date:  2021-06-08       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.